Oleg N. Vassiliev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Oleg N. Vassiliev has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
Radhe Mohan
Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
19 shared publications- Stephen Frasier Kry
Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
13 shared publications Uwe Titt
Department of Radiation Physics The University of Texas M. D. Anderson Cancer Center Houston Texas U.S.A.
10 shared publicationsFalk Pönisch
Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany 01307
6 shared publications- Radhe Mohan
Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, Texas
5 shared publications H. Helen Liu
4 shared publications
Latest Publications
- Open Access
- 28 July 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 70 (15) , 155004
A novel microdosimetry-based formalism for cell survival modelling applicable to hypofractionated radiotherapy
Objectives. Hypofractionated radiotherapy requires reliable cell survival models for doses much higher than the standard 2 Gy, for which the linear-quadratic (LQ) model is not applicable. We developed an alternative approach applicable to both low doses and high doses used in hypofractionated treatments and radiobiological experiments. Approach. We combined a standard microdosimetric technique with a recently introduced non-LQ cell survival model. Our formulation accounts for cell damage by multi-track events involving any number of particles. This is necessary for modelling cell survival at therapeutic doses. We characterise each cell type by the size R of the sensitive volume (SV) and biological response function B(q), where q is the total energy deposited in the SV after a given dose is delivered. q is a random quantity characterised by a probability density (microdosimetric spectrum) calculate with Geant4. We determine R and B(q) through an optimisation procedure that minimises differences between model predictions and cell survival measurements that cover an appropriate linear energy transfer (LET) range. Main results. Our method eliminated a serious flaw of the standard microdosimetric approach—arbitrary SV size. We determine SV size by solving the above optimisation problem. Furthermore, our method drastically simplifies calculations of multi-particle microdosimetric spectra. We applied our approach to 24 proton survival curves for three cell lines with various irradiation conditions and LET range of 0.589–19.6 keV µm−1 with good agreement between all these measurements and the model. R for a given cell type depended on fluence spectrum and increased with increasing LET owing to variations in the development and spatial spread of damage triggered by initial physical impact. This differ from the standard microdosimetry where SV size is constant. Significance. Our model is relatively simple and suitable for implementation in a treatment planning system potentially improving treatment plan optimisation, calculation of RBEs and biologically equivalent doses.
- 28 July 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 70 (15) , 155004
Open AccessA novel microdosimetry-based formalism for cell survival modelling applicable to hypofractionated radiotherapy
Objectives. Hypofractionated radiotherapy requires reliable cell survival models for doses much higher than the standard 2 Gy, for which the linear-quadratic (LQ) model is not applicable. We developed an alternative approach applicable to both low doses and high doses used in hypofractionated treatments and radiobiological experiments. Approach. We combined a standard microdosimetric technique with a recently introduced non-LQ cell survival model. Our formulation accounts for cell damage by multi-track events involving any number of particles. This is necessary for modelling cell survival at therapeutic doses. We characterise each cell type by the size R of the sensitive volume (SV) and biological response function B(q), where q is the total energy deposited in the SV after a given dose is delivered. q is a random quantity characterised by a probability density (microdosimetric spectrum) calculate with Geant4. We determine R and B(q) through an optimisation procedure that minimises differences between model predictions and cell survival measurements that cover an appropriate linear energy transfer (LET) range. Main results. Our method eliminated a serious flaw of the standard microdosimetric approach—arbitrary SV size. We determine SV size by solving the above optimisation problem. Furthermore, our method drastically simplifies calculations of multi-particle microdosimetric spectra. We applied our approach to 24 proton survival curves for three cell lines with various irradiation conditions and LET range of 0.589–19.6 keV µm−1 with good agreement between all these measurements and the model. R for a given cell type depended on fluence spectrum and increased with increasing LET owing to variations in the development and spatial spread of damage triggered by initial physical impact. This differ from the standard microdosimetry where SV size is constant. Significance. Our model is relatively simple and suitable for implementation in a treatment planning system potentially improving treatment plan optimisation, calculation of RBEs and biologically equivalent doses.
- Open Access
- 19 December 2022
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 68 (1) , 015004
Accumulation of sublethal radiation damage and its effect on cell survival
Objective. Determine the extent of sublethal radiation damage (SRD) in a cell population that received a given dose of radiation and the impact of this damage on cell survival. Approach. We developed a novel formalism to account for accumulation of SRD with increasing dose. It is based on a very general formula for cell survival that correctly predicts the basic properties of cell survival curves, such as the transition from the linear-quadratic to a linear dependence at high doses. Using this formalism we analyzed extensive experimental data for photons, protons and heavy ions to evaluate model parameters, quantify the extent of SRD and its impact on cell survival. Main results. Significant accumulation of SRD begins at doses below 1 Gy. As dose increases, so does the number of damaged cells and the amount of SRD in individual cells. SRD buildup in a cell increases the likelihood of complex irrepairable damage. For this reason, during a dose fraction delivery, each dose increment makes cells more radiosensitive. This gradual radosensitization is evidenced by the increasing slope of survival curves observed experimentally. It continues until the fraction is delivered, unless radiosensitivity reaches its maximum first. The maximum radiosensitivity is achieved when SRD accumulated in most cells is the maximum damage they can repair. After this maximum is reached, the slope of a survival curve, logarithm of survival versus dose, becomes constant, dose independent. The survival curve becomes a straight line, as experimental data at high doses show. These processes are random. They cause large cell-to-cell variability in the extent of damage and radiosensitivity of individual cells. Significance. SRD is in effect a radiosensitizer and its accumulation is a significant factor affecting cell survival, especially at high doses. We developed a novel formalism to study this phenomena and reported pertinent data for several particle types.
- 19 December 2022
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 68 (1) , 015004
Open AccessAccumulation of sublethal radiation damage and its effect on cell survival
Objective. Determine the extent of sublethal radiation damage (SRD) in a cell population that received a given dose of radiation and the impact of this damage on cell survival. Approach. We developed a novel formalism to account for accumulation of SRD with increasing dose. It is based on a very general formula for cell survival that correctly predicts the basic properties of cell survival curves, such as the transition from the linear-quadratic to a linear dependence at high doses. Using this formalism we analyzed extensive experimental data for photons, protons and heavy ions to evaluate model parameters, quantify the extent of SRD and its impact on cell survival. Main results. Significant accumulation of SRD begins at doses below 1 Gy. As dose increases, so does the number of damaged cells and the amount of SRD in individual cells. SRD buildup in a cell increases the likelihood of complex irrepairable damage. For this reason, during a dose fraction delivery, each dose increment makes cells more radiosensitive. This gradual radosensitization is evidenced by the increasing slope of survival curves observed experimentally. It continues until the fraction is delivered, unless radiosensitivity reaches its maximum first. The maximum radiosensitivity is achieved when SRD accumulated in most cells is the maximum damage they can repair. After this maximum is reached, the slope of a survival curve, logarithm of survival versus dose, becomes constant, dose independent. The survival curve becomes a straight line, as experimental data at high doses show. These processes are random. They cause large cell-to-cell variability in the extent of damage and radiosensitivity of individual cells. Significance. SRD is in effect a radiosensitizer and its accumulation is a significant factor affecting cell survival, especially at high doses. We developed a novel formalism to study this phenomena and reported pertinent data for several particle types.
- 20 November 2020
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 7 (1) , 015001
On calculation of the average linear energy transfer for radiobiological modelling
Applying the concept of linear energy transfer (LET) to modelling of biological effects of charged particles usually involves calculation of the average LET. To calculate this, the energy distribution of particles is characterized by either the source spectrum or fluence spectrum. Also, the average can be frequency- or dose-weighted. This makes four methods of calculating the average LET, each producing a different number. The purpose of this note is to describe which of these four methods is best suited for radiobiological modelling. We focused on data for photons (x-rays and gamma radiation) because in this case differences in the four averaging methods are most pronounced. However, our conclusions are equally applicable to photons and hadrons. We based our arguments on recently emerged Monte Carlo data that fully account for transport of electrons down to very low energies comparable to the ionization potential of water. We concluded that the frequency average LET calculated using the fluence spectrum has better predictive power than does that calculated using any of the other three options. This optimal method is not new but is different from those currently dominating research in this area.
- 20 November 2020
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 7 (1) , 015001
On calculation of the average linear energy transfer for radiobiological modelling
Applying the concept of linear energy transfer (LET) to modelling of biological effects of charged particles usually involves calculation of the average LET. To calculate this, the energy distribution of particles is characterized by either the source spectrum or fluence spectrum. Also, the average can be frequency- or dose-weighted. This makes four methods of calculating the average LET, each producing a different number. The purpose of this note is to describe which of these four methods is best suited for radiobiological modelling. We focused on data for photons (x-rays and gamma radiation) because in this case differences in the four averaging methods are most pronounced. However, our conclusions are equally applicable to photons and hadrons. We based our arguments on recently emerged Monte Carlo data that fully account for transport of electrons down to very low energies comparable to the ionization potential of water. We concluded that the frequency average LET calculated using the fluence spectrum has better predictive power than does that calculated using any of the other three options. This optimal method is not new but is different from those currently dominating research in this area.
- 16 October 2020
- Published by Cambridge University Press (CUP) in Journal of Radiotherapy in Practice
- Vol. 21 (1) , 81-87
Monte Carlo evaluation of target dose coverage in lung stereotactic body radiation therapy with flattening filter-free beams
Aim: Previous studies showed that replacing conventional flattened beams (FF) with flattening filter-free (FFF) beams improves the therapeutic ratio in lung stereotactic body radiation therapy (SBRT), but these findings could have been impacted by dose calculation uncertainties caused by the heterogeneity of the thoracic anatomy and by respiratory motion, which were particularly high for target coverage. In this study, we minimised such uncertainties by calculating doses using high-spatial-resolution Monte Carlo and four-dimensional computed tomography (4DCT) images. We aimed to evaluate more reliably the benefits of using FFF beams for lung SBRT. Materials and methods: For a cohort of 15 patients with early-stage lung cancer that we investigated in a previous treatment planning study, we recalculated dose distributions with Monte Carlo using 4DCT images. This included 15 FF and 15 FFF treatment plans. Results: Compared to Monte Carlo, the treatment planning system (TPS) over-predicted doses in low-dose regions of the planning target volume (PTV). For most patients, replacing FF beams with FFF beams improved target coverage, tumour control, and uncomplicated tumour control probabilities. Conclusions: Monte Carlo tends to reveal deficiencies in target coverage compared to coverage predicted by the TPS. Our data support previously reported benefits of using FFF beams for lung SBRT.
- 16 October 2020
- Published by Cambridge University Press (CUP) in Journal of Radiotherapy in Practice
- Vol. 21 (1) , 81-87
Monte Carlo evaluation of target dose coverage in lung stereotactic body radiation therapy with flattening filter-free beams
Aim: Previous studies showed that replacing conventional flattened beams (FF) with flattening filter-free (FFF) beams improves the therapeutic ratio in lung stereotactic body radiation therapy (SBRT), but these findings could have been impacted by dose calculation uncertainties caused by the heterogeneity of the thoracic anatomy and by respiratory motion, which were particularly high for target coverage. In this study, we minimised such uncertainties by calculating doses using high-spatial-resolution Monte Carlo and four-dimensional computed tomography (4DCT) images. We aimed to evaluate more reliably the benefits of using FFF beams for lung SBRT. Materials and methods: For a cohort of 15 patients with early-stage lung cancer that we investigated in a previous treatment planning study, we recalculated dose distributions with Monte Carlo using 4DCT images. This included 15 FF and 15 FFF treatment plans. Results: Compared to Monte Carlo, the treatment planning system (TPS) over-predicted doses in low-dose regions of the planning target volume (PTV). For most patients, replacing FF beams with FFF beams improved target coverage, tumour control, and uncomplicated tumour control probabilities. Conclusions: Monte Carlo tends to reveal deficiencies in target coverage compared to coverage predicted by the TPS. Our data support previously reported benefits of using FFF beams for lung SBRT.
- Open Access
- 30 July 2020
- Published by Cambridge University Press (CUP) in Journal of Radiotherapy in Practice
- Vol. 20 (4) , 419-425
Using FFF beams to improve the therapeutic ratio of lung SBRT
Aim:The aim of this study was to investigate the extent to which lung stereotactic body radiotherapy (SBRT) treatment plans can be improved by replacing conventional flattening filter (FF) beams with flattening filter-free (FFF) beams.Materials and methods:We selected 15 patients who had received SBRT with conventional 6-MV photon beams for early-stage lung cancer. We imported the patients’ treatment plans into the Eclipse 13·6 treatment planning system, in which we configured the AAA dose calculation model using representative beam data for a TrueBeam accelerator operated in 6-MV FFF mode. We then created new treatment plans by replacing the conventional FF beams in the original plans with FFF beams.Results:The FFF plans had better target coverage than the original FF plans did. For the planning target volume, FFF plans significantly improved the D98, D95, D90, homogeneity index and uncomplicated tumour control probability. In most cases, the doses to organs at risk were lower in FFF plans. FFF plans significantly reduced the mean lung dose, V10, V20, V30, and normal tissue complication probability for the total lung and improved the dosimetric indices for the ipsilateral lung. For most patients, FFF beams achieved lower maximum doses to the oesophagus, heart and the spinal cord, and a lower chest wall V30.Conclusions:Compared with FF beams, FFF beams achieved lower doses to organs at risk, especially the lung, without compromising tumour coverage; in fact, FFF beams improved coverage in most cases. Thus, replacing FF beams with FFF beams can achieve a better therapeutic ratio.
- 30 July 2020
- Published by Cambridge University Press (CUP) in Journal of Radiotherapy in Practice
- Vol. 20 (4) , 419-425
Open AccessUsing FFF beams to improve the therapeutic ratio of lung SBRT
Aim:The aim of this study was to investigate the extent to which lung stereotactic body radiotherapy (SBRT) treatment plans can be improved by replacing conventional flattening filter (FF) beams with flattening filter-free (FFF) beams.Materials and methods:We selected 15 patients who had received SBRT with conventional 6-MV photon beams for early-stage lung cancer. We imported the patients’ treatment plans into the Eclipse 13·6 treatment planning system, in which we configured the AAA dose calculation model using representative beam data for a TrueBeam accelerator operated in 6-MV FFF mode. We then created new treatment plans by replacing the conventional FF beams in the original plans with FFF beams.Results:The FFF plans had better target coverage than the original FF plans did. For the planning target volume, FFF plans significantly improved the D98, D95, D90, homogeneity index and uncomplicated tumour control probability. In most cases, the doses to organs at risk were lower in FFF plans. FFF plans significantly reduced the mean lung dose, V10, V20, V30, and normal tissue complication probability for the total lung and improved the dosimetric indices for the ipsilateral lung. For most patients, FFF beams achieved lower maximum doses to the oesophagus, heart and the spinal cord, and a lower chest wall V30.Conclusions:Compared with FF beams, FFF beams achieved lower doses to organs at risk, especially the lung, without compromising tumour coverage; in fact, FFF beams improved coverage in most cases. Thus, replacing FF beams with FFF beams can achieve a better therapeutic ratio.
- 4 June 2020
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 93 (1112) , 20190949
A simple model for calculating relative biological effectiveness of X-rays and gamma radiation in cell survival
Objectives: The relative biological effectiveness (RBE) of X-rays and γ radiation increases substantially with decreasing beam energy. This trend affects the efficacy of medical applications of this type of radiation. This study was designed to develop a model based on a survey of experimental data that can reliably predict this trend. Methods: In our model, parameters α and β of a cell survival curve are simple functions of the frequency-average linear energy transfer (LF) of delta electrons. The choice of these functions was guided by a microdosimetry-based model. We calculated LF by using an innovative algorithm in which LF is associated with only those electrons that reach a sensitive-to-radiation volume (SV) within the cell. We determined model parameters by fitting the model to 139 measured (α,β) pairs. Results: We tested nine versions of the model. The best agreement was achieved with α and β being linear functions of LF .The estimated SV diameter was 0.1–1 µm. We also found that α, β, and the α/β ratio increased with increasing LF . Conclusions: By combining an innovative method for calculating LF with a microdosimetric model, we developed a model that is consistent with extensive experimental data involving photon energies from 0.27 keV to 1.25 MeV. Advances in knowledge: We have developed a photon RBE model applicable to an energy range from ultra-soft X-rays to megaelectron volt γ radiation, including high-dose levels where the RBE cannot be calculated as the ratio of α values. In this model, the ionization density represented by LF determines the RBE for a given photon spectrum.
- 4 June 2020
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 93 (1112) , 20190949
A simple model for calculating relative biological effectiveness of X-rays and gamma radiation in cell survival
Objectives: The relative biological effectiveness (RBE) of X-rays and γ radiation increases substantially with decreasing beam energy. This trend affects the efficacy of medical applications of this type of radiation. This study was designed to develop a model based on a survey of experimental data that can reliably predict this trend. Methods: In our model, parameters α and β of a cell survival curve are simple functions of the frequency-average linear energy transfer (LF) of delta electrons. The choice of these functions was guided by a microdosimetry-based model. We calculated LF by using an innovative algorithm in which LF is associated with only those electrons that reach a sensitive-to-radiation volume (SV) within the cell. We determined model parameters by fitting the model to 139 measured (α,β) pairs. Results: We tested nine versions of the model. The best agreement was achieved with α and β being linear functions of LF .The estimated SV diameter was 0.1–1 µm. We also found that α, β, and the α/β ratio increased with increasing LF . Conclusions: By combining an innovative method for calculating LF with a microdosimetric model, we developed a model that is consistent with extensive experimental data involving photon energies from 0.27 keV to 1.25 MeV. Advances in knowledge: We have developed a photon RBE model applicable to an energy range from ultra-soft X-rays to megaelectron volt γ radiation, including high-dose levels where the RBE cannot be calculated as the ratio of α values. In this model, the ionization density represented by LF determines the RBE for a given photon spectrum.
- 9 January 2020
- Published by Cambridge University Press (CUP) in Journal of Radiotherapy in Practice
- Vol. 20 (1) , 12-16
Impact of intra-fractional motion on dose distributions in lung IMRT
Aim: To investigate the impact of intra-fractional motion on dose distribution in patients treated with intensity-modulated radiotherapy (IMRT) for lung cancer.Materials and methods: Twenty patients who had undergone IMRT for non-small cell lung cancer were selected for this retrospective study. For each patient, a four-dimensional computed tomography (CT) image set was acquired and clinical treatment plans were developed using the average CT. Dose distributions were then recalculated for each of the 10 phases of respiratory cycle and combined using deformable image registration to produce cumulative dose distributions that were compared with the clinical treatment plans.Results: Intra-fractional motion reduced planning target volume (PTV) coverage in all patients. The median reduction of PTV covered by the prescription isodose was 3·4%; D98 was reduced by 3·1 Gy. Changes in the mean lung dose were within ±0·7 Gy. V20 for the lung increased in most patients; the median increase was 1·6%. The dose to the spinal cord was unaffected by intra-fractional motion. The dose to the heart was slightly reduced in most patients. The median reduction in the mean heart dose was 0·22 Gy, and V30 was reduced by 2·5%. The maximum dose to the oesophagus was also reduced in most patients, by 0·74 Gy, whereas V50 did not change significantly. The median number of points in which dose differences exceeded 3%/3 mm was 6·2%.Findings: Intra-fractional anatomical changes reduce PTV coverage compared to the coverage predicted by clinical treatment planning systems that use the average CT for dose calculation. Doses to organs at risk were mostly over-predicted.
- 9 January 2020
- Published by Cambridge University Press (CUP) in Journal of Radiotherapy in Practice
- Vol. 20 (1) , 12-16
Impact of intra-fractional motion on dose distributions in lung IMRT
Aim: To investigate the impact of intra-fractional motion on dose distribution in patients treated with intensity-modulated radiotherapy (IMRT) for lung cancer.Materials and methods: Twenty patients who had undergone IMRT for non-small cell lung cancer were selected for this retrospective study. For each patient, a four-dimensional computed tomography (CT) image set was acquired and clinical treatment plans were developed using the average CT. Dose distributions were then recalculated for each of the 10 phases of respiratory cycle and combined using deformable image registration to produce cumulative dose distributions that were compared with the clinical treatment plans.Results: Intra-fractional motion reduced planning target volume (PTV) coverage in all patients. The median reduction of PTV covered by the prescription isodose was 3·4%; D98 was reduced by 3·1 Gy. Changes in the mean lung dose were within ±0·7 Gy. V20 for the lung increased in most patients; the median increase was 1·6%. The dose to the spinal cord was unaffected by intra-fractional motion. The dose to the heart was slightly reduced in most patients. The median reduction in the mean heart dose was 0·22 Gy, and V30 was reduced by 2·5%. The maximum dose to the oesophagus was also reduced in most patients, by 0·74 Gy, whereas V50 did not change significantly. The median number of points in which dose differences exceeded 3%/3 mm was 6·2%.Findings: Intra-fractional anatomical changes reduce PTV coverage compared to the coverage predicted by clinical treatment planning systems that use the average CT for dose calculation. Doses to organs at risk were mostly over-predicted.
- 4 November 2019
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 64 (21) , 215018
Systematic microdosimetric data for protons of therapeutic energies calculated with Geant4-DNA
The purpose of this study was to generate physical data needed for microdosimetry-based models of proton RBE. Our focus was on the frequency and dose average lineal energies, y F and y D . We report data for proton energies from 0.1 to 100 MeV, for spherical volumes 2–10 3 nm in diameter. These data were calculated using Geant4-DNA Monte Carlo software. The physics implemented in Geant4-DNA has been extensively tested for this type of calculations but data on y F and y D for protons generated with this code have been very limited. An innovative aspect of our study is that we introduced a straightforward procedure for calculation of y F and y D for polyenergetic beams and presented the data in a format that simplifies these calculations. We compared our data with previous studies that used different Monte Carlo codes and with experimental data.
- 4 November 2019
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 64 (21) , 215018
Systematic microdosimetric data for protons of therapeutic energies calculated with Geant4-DNA
The purpose of this study was to generate physical data needed for microdosimetry-based models of proton RBE. Our focus was on the frequency and dose average lineal energies, y F and y D . We report data for proton energies from 0.1 to 100 MeV, for spherical volumes 2–10 3 nm in diameter. These data were calculated using Geant4-DNA Monte Carlo software. The physics implemented in Geant4-DNA has been extensively tested for this type of calculations but data on y F and y D for protons generated with this code have been very limited. An innovative aspect of our study is that we introduced a straightforward procedure for calculation of y F and y D for polyenergetic beams and presented the data in a format that simplifies these calculations. We compared our data with previous studies that used different Monte Carlo codes and with experimental data.
- 28 September 2018
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 63 (19) , 195007
Radiotherapy of lung cancers: FFF beams improve dose coverage at tumor periphery compromised by electronic disequilibrium
The purpose of this work was to investigate radiotherapy underdosing at the periphery of lung tumors, and differences in dose for treatments delivered with flattening filter-free (FFF) beams and with conventional flattened (FF) beams. The true differences between these delivery approaches, as assessed with Monte Carlo simulations, were compared to the apparent differences seen with clinical treatment planning algorithms AAA and Acuros XB. Dose was calculated in a phantom comprised of a chest wall, lung parenchyma, and a spherical tumor (tested diameters: 1, 3, and 5 cm). Three lung densities were considered: 0.26, 0.2, and 0.1 g cm −3 , representing normal lung, lung at full inspiration, and emphysematous lung, respectively. The dose was normalized to 50 Gy to the tumor center and delivered with 7 coplanar, unmodulated 6 MV FFF or FF beams. Monte Carlo calculations used EGSnrc and phase space files for the TrueBeam accelerator provided by Varian Medical Systems. Voxel sizes were 0.5 mm for the 1 cm tumor and 1 mm for the larger tumors. AAA and Acuros XB dose calculations were performed in Eclipse ™ with a 2.5 mm dose grid, the resolution normally used clinically. Monte Carlo dose distributions showed that traditional FF beams underdosed the periphery of the tumor by up to ~2 Gy as compared to FFF beams; the latter provided a more uniform dose throughout the tumor. In all cases, the underdosed region was a spherical shell about 5 mm thick around the tumor and extending into the tumor by 2–3 mm. The effect was most pronounced for smaller tumors and lower lung densities. The underdosing observed with conventional FF beams was not captured by the clinical treatment planning systems. We concluded that FFF beams mitigate dose loss at tumor periphery and current clinical practice fails to capture tumor periphery underdosing and possible ways to mitigate it.
- 28 September 2018
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 63 (19) , 195007
Radiotherapy of lung cancers: FFF beams improve dose coverage at tumor periphery compromised by electronic disequilibrium
The purpose of this work was to investigate radiotherapy underdosing at the periphery of lung tumors, and differences in dose for treatments delivered with flattening filter-free (FFF) beams and with conventional flattened (FF) beams. The true differences between these delivery approaches, as assessed with Monte Carlo simulations, were compared to the apparent differences seen with clinical treatment planning algorithms AAA and Acuros XB. Dose was calculated in a phantom comprised of a chest wall, lung parenchyma, and a spherical tumor (tested diameters: 1, 3, and 5 cm). Three lung densities were considered: 0.26, 0.2, and 0.1 g cm −3 , representing normal lung, lung at full inspiration, and emphysematous lung, respectively. The dose was normalized to 50 Gy to the tumor center and delivered with 7 coplanar, unmodulated 6 MV FFF or FF beams. Monte Carlo calculations used EGSnrc and phase space files for the TrueBeam accelerator provided by Varian Medical Systems. Voxel sizes were 0.5 mm for the 1 cm tumor and 1 mm for the larger tumors. AAA and Acuros XB dose calculations were performed in Eclipse ™ with a 2.5 mm dose grid, the resolution normally used clinically. Monte Carlo dose distributions showed that traditional FF beams underdosed the periphery of the tumor by up to ~2 Gy as compared to FFF beams; the latter provided a more uniform dose throughout the tumor. In all cases, the underdosed region was a spherical shell about 5 mm thick around the tumor and extending into the tumor by 2–3 mm. The effect was most pronounced for smaller tumors and lower lung densities. The underdosing observed with conventional FF beams was not captured by the clinical treatment planning systems. We concluded that FFF beams mitigate dose loss at tumor periphery and current clinical practice fails to capture tumor periphery underdosing and possible ways to mitigate it.
- Open Access
- 1 March 2018
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 63 (5) , 055007
Average stopping powers for electron and photon sources for radiobiological modeling and microdosimetric applications
This study concerns calculation of the average electronic stopping power for photon and electron sources. It addresses two problems that have not yet been fully resolved. The first is defining the electron spectrum used for averaging in a way that is most suitable for radiobiological modeling. We define it as the spectrum of electrons entering the sensitive to radiation volume (SV) within the cell nucleus, at the moment they enter the SV. For this spectrum we derive a formula that combines linearly the fluence spectrum and the source spectrum. The latter is the distribution of initial energies of electrons produced by a source. Previous studies used either the fluence or source spectra, but not both, thereby neglecting a part of the complete spectrum. Our derived formula reduces to these two prior methods in the case of high and low energy sources, respectively. The second problem is extending electron spectra to low energies. Previous studies used an energy cut-off on the order of 1 keV. However, as we show, even for high energy sources, such as 60 Co, electrons with energies below 1 keV contribute about 30% to the dose. In this study all the spectra were calculated with Geant4-DNA code and a cut-off energy of only 11 eV. We present formulas for calculating frequency- and dose-average stopping powers, numerical results for several important electron and photon sources, and tables with all the data needed to use our formulas for arbitrary electron and photon sources producing electrons with initial energies up to ∼1 MeV.
- 1 March 2018
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 63 (5) , 055007
Open AccessAverage stopping powers for electron and photon sources for radiobiological modeling and microdosimetric applications
This study concerns calculation of the average electronic stopping power for photon and electron sources. It addresses two problems that have not yet been fully resolved. The first is defining the electron spectrum used for averaging in a way that is most suitable for radiobiological modeling. We define it as the spectrum of electrons entering the sensitive to radiation volume (SV) within the cell nucleus, at the moment they enter the SV. For this spectrum we derive a formula that combines linearly the fluence spectrum and the source spectrum. The latter is the distribution of initial energies of electrons produced by a source. Previous studies used either the fluence or source spectra, but not both, thereby neglecting a part of the complete spectrum. Our derived formula reduces to these two prior methods in the case of high and low energy sources, respectively. The second problem is extending electron spectra to low energies. Previous studies used an energy cut-off on the order of 1 keV. However, as we show, even for high energy sources, such as 60 Co, electrons with energies below 1 keV contribute about 30% to the dose. In this study all the spectra were calculated with Geant4-DNA code and a cut-off energy of only 11 eV. We present formulas for calculating frequency- and dose-average stopping powers, numerical results for several important electron and photon sources, and tables with all the data needed to use our formulas for arbitrary electron and photon sources producing electrons with initial energies up to ∼1 MeV.